Although HGF copy number was not prognostic in patients with triple-negative tumours in either of the cohorts, high stromal HGF, but not cytoplasmic HGF, was correlated with a shorter DRFS in these patients in cohort 1 (HR = 2.93; 95% CI: 1.06-8.09, p=0.04 and HR = 1.0; 95% CI: 0.4-2.4, p=0.9, respectively). This evidence concerns the gene HGF and neoplasm.